| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients
|
Göbel, Andy
|
|
2017
|
164 |
3 |
p. 737-743
|
artikel
|
| 2 |
Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™
|
Dahlbäck, Cecilia
|
|
2017
|
164 |
3 |
p. 679-687
|
artikel
|
| 3 |
A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy
|
Kim, Ji-Yeon
|
|
2017
|
164 |
3 |
p. 617-625
|
artikel
|
| 4 |
Benefit of adding digital breast tomosynthesis to digital mammography for breast cancer screening focused on cancer characteristics: a meta-analysis
|
Yun, Seong Jong
|
|
2017
|
164 |
3 |
p. 557-569
|
artikel
|
| 5 |
Childhood and teenage physical activity and breast cancer risk
|
Niehoff, Nicole M.
|
|
2017
|
164 |
3 |
p. 697-705
|
artikel
|
| 6 |
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
|
Maxwell, Kara N.
|
|
2017
|
164 |
3 |
p. 627-638
|
artikel
|
| 7 |
Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer
|
Rummel, Seth K.
|
|
2017
|
164 |
3 |
p. 593-601
|
artikel
|
| 8 |
Critical appraisal of health-state utility values used in breast cancer-related cost–utility analyses
|
Nerich, Virginie
|
|
2017
|
164 |
3 |
p. 527-536
|
artikel
|
| 9 |
Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography
|
Rafferty, Elizabeth A.
|
|
2017
|
164 |
3 |
p. 659-666
|
artikel
|
| 10 |
Elevated T cell activation score is associated with improved survival of breast cancer
|
Lu, Lingeng
|
|
2017
|
164 |
3 |
p. 689-696
|
artikel
|
| 11 |
Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
|
Cintolo-Gonzalez, Jessica A.
|
|
2017
|
164 |
3 |
p. 745
|
artikel
|
| 12 |
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
|
Maxwell, Kara N.
|
|
2017
|
164 |
3 |
p. 639-640
|
artikel
|
| 13 |
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
|
Ahlin, Cecilia
|
|
2017
|
164 |
3 |
p. 667-678
|
artikel
|
| 14 |
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
|
Ho, Diep
|
|
2017
|
164 |
3 |
p. 571-580
|
artikel
|
| 15 |
Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer
|
Ruddy, Kathryn J.
|
|
2017
|
164 |
3 |
p. 515-525
|
artikel
|
| 16 |
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
|
Scannell Bryan, Molly
|
|
2017
|
164 |
3 |
p. 707-717
|
artikel
|
| 17 |
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
|
Cabarrou, B.
|
|
2017
|
164 |
3 |
p. 505-513
|
artikel
|
| 18 |
Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results
|
Narayan, Anand
|
|
2017
|
164 |
3 |
p. 719-725
|
artikel
|
| 19 |
Radiation and depression associated with complications of tissue expander reconstruction
|
Chuba, Paul J.
|
|
2017
|
164 |
3 |
p. 641-647
|
artikel
|
| 20 |
Risk of death from cardiovascular disease following breast cancer: a systematic review
|
Gernaat, S. A. M.
|
|
2017
|
164 |
3 |
p. 537-555
|
artikel
|
| 21 |
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
|
Yardley, Denise A.
|
|
2017
|
164 |
3 |
p. 649-658
|
artikel
|
| 22 |
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
|
Lewis Phillips, Gail D.
|
|
2017
|
164 |
3 |
p. 581-591
|
artikel
|
| 23 |
Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer
|
Kelkar, Madhura G.
|
|
2017
|
164 |
3 |
p. 603-615
|
artikel
|
| 24 |
Women with breast cancer report substantially more disease- and treatment-related side or late effects than registered by clinical oncologists: a cross-sectional study of a standard follow-up program in an oncological department
|
Ellegaard, Mai-Britt Bjørklund
|
|
2017
|
164 |
3 |
p. 727-736
|
artikel
|
Tijdschrift beschrijving